AeroSafe GlobalAlongside the imminent challenge of COVID-19 vaccine development and approval stands the complex challenge of urgent distribution—effectively, safely, while the entire world is watching and waiting.
At AeroSafe Global, we've pioneered cold-chain-as-a-service (CCaaS) technologies and solutions for shipping temperature-sensitive medicines, including COVID-19 vaccines. Our trusted solution is based on our high-performing technology, experienced global footprint, and excellent end-user engagement services.
Our solution is an important part of a cold chain strategy that gives you the confidence that your vaccines will be protected every step of the way, with no exceptions.
